ORTHOFIX MED INC
| Market Cap | $494.58M |
| P/E Ratio | — |
| Forward P/E | 14.41 |
| Dividend Yield | — |
| Beta | 0.78 |
| 52W Range | $10.24 - $17.28 |
| # Hedge Funds | 0 |
| Sector | Healthcare |
| Industry | Medical Devices |
Hedge Fund Ownership
| Investor 0 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|
Insider Trading
| Insider Name of the company insider who made the trade 39 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Vitale LucasCP&BOO | Sale | 4,269 | $11.92 | $50.89K | 17 Mar 2026 | 17 Mar 2026 |
| CAPPS VICKIE L | Buy | 2,400 | $12.45 | $29.88K | 10 Mar 2026 | 09 Mar 2026 |
| CAPPS VICKIE L | Buy | 100 | $12.44 | $1.24K | 10 Mar 2026 | 09 Mar 2026 |
| CAPPS VICKIE L | Buy | 2,500 | $12.48 | $31.20K | 09 Mar 2026 | 09 Mar 2026 |
| REINHARDT MAXPresident, Global Spine | Sale | 1,053 | $12.55 | $13.22K | 05 Mar 2026 | 06 Mar 2026 |
| Calafiore MassimoPresident & CEO | Sale | 6,031 | $12.55 | $75.69K | 05 Mar 2026 | 06 Mar 2026 |
| Fisher PatrickPresident, Global Limb Recon | Sale | 758 | $12.55 | $9.51K | 05 Mar 2026 | 06 Mar 2026 |
| Vitale LucasCP&BOO | Sale | 1,141 | $12.55 | $14.32K | 05 Mar 2026 | 06 Mar 2026 |
| Cedron Jorge AndresCLO | Sale | 1,370 | $12.55 | $17.19K | 05 Mar 2026 | 06 Mar 2026 |
| McPherron AvivaPres, Global Ops & Qual | Sale | 1,263 | $12.55 | $15.85K | 05 Mar 2026 | 06 Mar 2026 |
| Andrews JulieCFO | Sale | 2,363 | $12.55 | $29.66K | 05 Mar 2026 | 06 Mar 2026 |
| Lucas VitaleCP&BOO | Sale | 1,141 | $12.55 | $14.32K | 05 Mar 2026 | 06 Mar 2026 |
| Max ReinhardtPresident, Global Spine | Sale | 1,053 | $12.55 | $13.22K | 05 Mar 2026 | 06 Mar 2026 |
| Aviva McpherronPres, Global Ops & Qual | Sale | 1,263 | $12.55 | $15.85K | 05 Mar 2026 | 06 Mar 2026 |
| Massimo CalafiorePresident & CEO | Sale | 6,031 | $12.55 | $75.69K | 05 Mar 2026 | 06 Mar 2026 |
| Patrick FisherPresident, Global Limb Recon | Sale | 758 | $12.55 | $9.51K | 05 Mar 2026 | 06 Mar 2026 |
| Jorge Andres CedronCLO | Sale | 1,370 | $12.55 | $17.19K | 05 Mar 2026 | 06 Mar 2026 |
| Julie AndrewsCFO | Sale | 2,363 | $12.55 | $29.66K | 05 Mar 2026 | 06 Mar 2026 |
| Cedron Jorge AndresCLO | Sale | 1,405 | $12.92 | $18.15K | 04 Mar 2026 | 06 Mar 2026 |
| Fisher PatrickPresident, Global Limb Recon | Sale | 778 | $12.92 | $10.05K | 04 Mar 2026 | 06 Mar 2026 |
| Vitale LucasCP&BOO | Sale | 1,171 | $12.92 | $15.12K | 04 Mar 2026 | 06 Mar 2026 |
| REINHARDT MAXPresident, Global Spine | Sale | 1,080 | $12.92 | $13.95K | 04 Mar 2026 | 06 Mar 2026 |
| Calafiore MassimoPresident & CEO | Sale | 6,189 | $12.92 | $79.94K | 04 Mar 2026 | 06 Mar 2026 |
| McPherron AvivaPres, Global Ops & Qual | Sale | 1,296 | $12.92 | $16.74K | 04 Mar 2026 | 06 Mar 2026 |
| Andrews JulieCFO | Sale | 2,425 | $12.92 | $31.32K | 04 Mar 2026 | 06 Mar 2026 |
| Julie AndrewsCFO | Sale | 2,425 | $12.92 | $31.32K | 04 Mar 2026 | 06 Mar 2026 |
| Lucas VitaleCP&BOO | Sale | 1,171 | $12.92 | $15.12K | 04 Mar 2026 | 06 Mar 2026 |
| Aviva McpherronPres, Global Ops & Qual | Sale | 1,296 | $12.92 | $16.74K | 04 Mar 2026 | 06 Mar 2026 |
| Max ReinhardtPresident, Global Spine | Sale | 1,080 | $12.92 | $13.95K | 04 Mar 2026 | 06 Mar 2026 |
| Patrick FisherPresident, Global Limb Recon | Sale | 778 | $12.92 | $10.05K | 04 Mar 2026 | 06 Mar 2026 |
| Massimo CalafiorePresident & CEO | Sale | 6,189 | $12.92 | $79.94K | 04 Mar 2026 | 06 Mar 2026 |
| Jorge Andres CedronCLO | Sale | 1,405 | $12.92 | $18.15K | 04 Mar 2026 | 06 Mar 2026 |
| Engine Capital Management, LP | Buy | 9,959 | $12.96 | $129.10K | 25 Feb 2026 | 26 Feb 2026 |
| Engine Capital Management, LP | Buy | 3,102 | $12.96 | $40.21K | 25 Feb 2026 | 26 Feb 2026 |
| Engine Capital Management, LP | Buy | 7,721 | $12.55 | $96.86K | 24 Feb 2026 | 26 Feb 2026 |
| Engine Capital Management, LP | Buy | 117,076 | $12.55 | $1.47M | 24 Feb 2026 | 26 Feb 2026 |
| Andrews JulieCFO | Sale | 4,873 | $14.38 | $70.07K | 16 Jan 2026 | 21 Jan 2026 |
| Calafiore MassimoPresident & CEO | Sale | 9,797 | $15.21 | $149.05K | 12 Jan 2026 | 13 Jan 2026 |
| Calafiore MassimoPresident & CEO | Sale | 9,600 | $15.82 | $151.91K | 09 Jan 2026 | 13 Jan 2026 |
Frequently Asked Questions
What is OFIX stock price today?
ORTHOFIX MED INC (OFIX) is currently trading at $12.32. The stock has a 52-week range of $10.24 to $17.28 and a market capitalization of $494.58M.
Is OFIX a good stock to buy in 2026?
ORTHOFIX MED INC has a P/E ratio of N/A (forward P/E: 14.4), a dividend yield of none, and 1-year performance of -27.5%. 0 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling OFIX stock?
There have been 39 insider transactions for OFIX in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has OFIX stock performed over the past year?
ORTHOFIX MED INC (OFIX) has returned -27.5% over the past 12 months. The stock traded between $10.24 and $17.28 during this period, and is currently at $12.32.
Which hedge funds own OFIX (ORTHOFIX MED INC)?
0 tracked hedge funds currently hold OFIX in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is OFIX's market cap and valuation?
ORTHOFIX MED INC (OFIX) has a market capitalization of $494.58M. The trailing P/E ratio is N/A and forward P/E is 14.4. The stock is classified in the Healthcare sector.
What is OFIX's revenue and profitability?
ORTHOFIX MED INC reported revenue of $822.31M with net income of N/A and a profit margin of N/A. The stock has a beta of 0.78.
What sector is OFIX in and who are its biggest institutional holders?
ORTHOFIX MED INC (OFIX) operates in the Healthcare sector. It is held by 0 tracked hedge funds. See the ownership table above for the complete list.